Inhibition of SOD1 expression by mitomycin C is a non-specific consequence of cellular toxicity

Neuroscience Letters

Volumn 393, Issue 2-3, 2006, Pages 184-188

  Broom, Wendy J ^a   Ay, Ilknur ^a   Pasinelli, Piera ^a   Brown Jr , Robert H ^a  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

ALS; Gene expression; Mitomycin C; SOD1

Indexed keywords

ACTIN; COPPER ZINC SUPEROXIDE DISMUTASE; MITOMYCIN C; PROTEIN P53;

AMYOTROPHIC LATERAL SCLEROSIS; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CELL VIABILITY; CONTROLLED STUDY; CYTOTOXICITY; DRUG EFFECT; ENZYME INHIBITION; FEMALE; HUMAN; HUMAN CELL; IN VITRO STUDY; IN VIVO STUDY; INHIBITION KINETICS; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; RAT; SPINAL CORD; WESTERN BLOTTING;

ANIMALS; ANTIBIOTICS, ANTINEOPLASTIC; BLOTTING, WESTERN; BRAIN; CASPASES; CELL LINE; CELL SURVIVAL; DOSE-RESPONSE RELATIONSHIP, DRUG; GENE EXPRESSION REGULATION; HUMANS; MALE; MICE; MICE, INBRED C57BL; MITOMYCIN; RATS; RATS, WISTAR; SPINAL CORD; SUPEROXIDE DISMUTASE;

EID: 29244440705     PISSN: 03043940     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.neulet.2005.09.064     Document Type: Article

References (16)

1. G.M. Alexander, K.L. Erwin, N. Byers, J.S. Deitch, B.J. Augelli, E.P. Blankenhorn, and T.D. Heiman-Patterson Effect of transgene copy number on survival in the G93A SOD1 transgenic mouse model of ALS Brain Res. Mol. Brain Res. 130 2004 7 15
2. P.M. Andersen, K.B. Sims, W.W. Xin, R. Kiely, G. O'Neill, J. Ravits, E. Pioro, Y. Harati, R.D. Brower, J.S. Levine, H.U. Heinicke, W. Seltzer, M. Boss, and R.H. Brown Jr. Sixteen novel mutations in the Cu/Zn superoxide dismutase gene in amyotrophic lateral sclerosis: a decade of discoveries, defects and disputes Amyotroph. Lateral Scler. Other Motor Neuron Disord. 4 2003 62 73
3. R.Y. Cheung, A.M. Rauth, and X. Yu Wu In vivo efficacy and toxicity of intratumorally delivered mitomycin C and its combination with doxorubicin using microsphere formulations Anticancer Drugs 16 2005 423 433
4. G. Cho, S. Kang, S.J. Seo, Y. Kim, and G. Jung The transcriptional repression of the human Cu/Zn superoxide dismutase (sod1) gene by the anticancer drug, mitomycin C (MMC) Biochem. Mol. Biol. Int. 42 1997 949 956
5. H.D. Durham, J. Roy, L. Dong, and D.A. Figlewicz Aggregation of mutant Cu/Zn superoxide dismutase proteins in a culture model of ALS J. Neuropathol. Exp. Neurol. 56 1997 523 530
6. S.U. Gnad-Vogt, R.D. Hofheinz, S. Saussele, S. Kreil, A. Willer, F. Willeke, L. Pilz, R. Hehlmann, and A. Hochhaus Pegylated liposomal doxorubicin and mitomycin C in combination with infusional 5-fluorouracil and sodium folinic acid in the treatment of advanced gastric cancer: results of a phase II trial Anticancer Drugs 16 2005 435 440
7. M.E. Gurney, H. Pu, A.Y. Chiu, M.C. Dal Canto, C.Y. Polchow, D.D. Alexander, J. Caliendo, A. Hentati, Y.W. Kwon, and H.X. Deng Motor neuron degeneration in mice that express a human Cu,Zn superoxide dismutase mutation Science 264 1994 1772 1775
8. J. Jacobsson, P.A. Jonsson, P.M. Andersen, L. Forsgren, and S.L. Marklund Superoxide dismutase in CSF from amyotrophic lateral sclerosis patients with and without CuZn-superoxide dismutase mutations Brain 124 2001 1461 1466
9. P.P. Khil, and R.D. Camerini-Otero Over 1000 genes are involved in the DNA damage response of Escherichia coli Mol. Microbiol. 44 2002 89 105
10. K.L. Kooistra, M. Rodriguez, and G. Powis Toxicity of intrathecally administered cytotoxic drugs and their antitumor activity against an intrathecal Walker 256 carcinosarcoma model for meningeal carcinomatosis in the rat Cancer Res. 49 1989 977 982
11. P. Pasinelli, D.R. Borchelt, M.K. Houseweart, D.W. Cleveland, and R.H. Brown Jr. Caspase-1 is activated in neural cells and tissue with amyotrophic lateral sclerosis-associated mutations in copper-zinc superoxide dismutase Proc. Natl. Acad. Sci. U.S.A. 95 1998 15763 15768 (published erratum appears in Proc. Natl. Acad. Sci. U.S.A. 16;96(6) (1999) 3330)
12. G.S. Ralph, P.A. Radcliffe, D.M. Day, J.M. Carthy, M.A. Leroux, D.C. Lee, L.F. Wong, L.G. Bilsland, L. Greensmith, S.M. Kingsman, K.A. Mitrophanous, N.D. Mazarakis, and M. Azzouz Silencing mutant SOD1 using RNAi protects against neurodegeneration and extends survival in an ALS model Nat. Med. 11 2005 429 433
13. A.G. Reaume, J.L. Elliott, E.K. Hoffman, N.W. Kowall, R.J. Ferrante, D.F. Siwek, H.M. Wilcox, D.G. Flood, M.F. Beal, R.H. Brown Jr., R.W. Scott, and W.D. Snider Motor neurons in Cu/Zn superoxide dismutase-deficient mice develop normally but exhibit enhanced cell death after axonal injury Nat. Genet. 13 1996 43 47
14. D.R. Rosen Mutations in Cu/Zn superoxide dismutase gene are associated with familial amyotrophic lateral sclerosis Nature 364 1993 362
15. C.E. Shaw, Z.E. Enayat, B.A. Chioza, A. Al-Chalabi, A. Radunovic, J.F. Powell, and P.N. Leigh Mutations in all five exons of SOD-1 may cause ALS Ann. Neurol. 43 1998 390 394
16. A. Stepczynska, K. Lauber, I.H. Engels, O. Janssen, D. Kabelitz, S. Wesselborg, and K. Schulze-Osthoff Staurosporine and conventional anticancer drugs induce overlapping, yet distinct pathways of apoptosis and caspase activation Oncogene 20 2001 1193 1202